scispace - formally typeset
F

Francesco Latrofa

Researcher at University of Pisa

Publications -  82
Citations -  2935

Francesco Latrofa is an academic researcher from University of Pisa. The author has contributed to research in topics: Thyroid & Thyroglobulin. The author has an hindex of 26, co-authored 67 publications receiving 2253 citations. Previous affiliations of Francesco Latrofa include World Health Organization & University of California, Los Angeles.

Papers
More filters
Journal ArticleDOI

Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens.

TL;DR: A large group of patients with differentiated thyroid carcinoma who had serum thyroid peroxidase, thyroglobulin, or TSH-receptor antibodies due to coexistent thyroid autoimmune disease were studied, finding gradual disappearance of antibodies gradually disappeared in most patients.
Journal ArticleDOI

Subacute Thyroiditis After Sars-COV-2 Infection.

TL;DR: The first case of SAT related to SARS-CoV-2 infection is reported and clinicians are alerted to additional and unreported clinical manifestations associated with COVID-19.
Journal ArticleDOI

The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim

TL;DR: Goiter and hyperthyroidism occur to a much greater extent when the adenovirus expresses the free A subunit as opposed to a genetically modified TSHR that cleaves minimally into subunits, and new insight is provided into the etiology of Graves disease.
Journal ArticleDOI

Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis

TL;DR: The results of the present study demonstrate that the mRNA encoding for the ACE-2 receptor is expressed in thyroid follicular cells, making them a potential target for SARS-COV-2 entry.
Journal ArticleDOI

Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor

TL;DR: Evidence supports the concept that A subunit shedding either initiates or amplifies the autoimmune response to the TSHR, thereby causing Graves disease in genetically susceptible individuals.